DOUGLAS REH
- Type
- Physician · Allopathic & Osteopathic Physicians / Otolaryngology
- Where
- Baltimore, MD
- NPI
- 1982725917
- Received
- $350,357 in 432 records, 2019 to 2025 ($230,750 general, $119,606 research)
- As principal investigator
- $330,726 of research payments to others in 47 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 66 | $48,597 |
| 2025 | Research payment | 3 | $28,512 |
| 2024 | General payment | 66 | $37,803 |
| 2024 | Research payment | 8 | $29,226 |
| 2023 | General payment | 65 | $27,575 |
| 2023 | Research payment | 9 | $49,493 |
| 2022 | General payment | 68 | $39,351 |
| 2022 | Research payment | 4 | $12,375 |
| 2021 | General payment | 50 | $34,798 |
| 2020 | General payment | 44 | $18,387 |
| 2019 | General payment | 49 | $24,237 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Neurent Medical Limited | 77 | $156,476 | 2022–2025 |
| Optinose US, Inc. | 120 | $91,521 | 2019–2025 |
| GENZYME CORPORATION | 11 | $26,970 | 2022–2025 |
| Integra LifeSciences Corporation | 50 | $26,777 | 2024–2025 |
| Medical Device Business Services, Inc. | 25 | $23,212 | 2020–2023 |
| Acclarent, Inc | 86 | $18,097 | 2019–2024 |
| Regeneron Healthcare Solutions, Inc. | 28 | $4,349 | 2021–2025 |
| Medtronic, Inc. | 11 | $1,626 | 2021–2025 |
| Intersect ENT, Inc. | 3 | $447 | 2019–2021 |
| Medtronic USA, Inc. | 3 | $204 | 2019–2020 |
| GlaxoSmithKline, LLC. | 4 | $188 | 2023–2025 |
| AERIN MEDICAL INC. | 4 | $125 | 2019–2023 |
| Stryker Corporation | 3 | $94 | 2020–2024 |
| AstraZeneca Pharmaceuticals LP | 1 | $79 | 2023 |
| 3-D Matrix, Inc. | 1 | $62 | 2022 |
| SANOFI-AVENTIS U.S. LLC | 1 | $33 | 2023 |
| PFIZER INC. | 1 | $23 | 2021 |
| Aimmune Therapeutics, Inc. | 1 | $23 | 2022 |
| ALK-Abello, Inc | 1 | $23 | 2021 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $18 | 2025 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 24 | $119,606 |
| Consulting Fee | 50 | $103,606 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 44 | $87,330 |
| Travel and Lodging | 37 | $21,205 |
| Food and Beverage | 272 | $14,236 |
| Honoraria | 3 | $4,250 |
| Education | 2 | $122 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-11-28 | Neurent Medical Limited | $1,875 | Research payment | Cash or cash equivalent | NEUROMARK System Device, Electrosurgical, Cutting & Coagulation & Accessories | NEUROMARK CRS Study - Clinical Study of NEUROMARK System in Patients with Chronic Rhinosinusitis | 2025 |
| 2025-11-18 | GENZYME CORPORATION | $3,283 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | DUPIXENT Biological, Immunology | 2025 | |
| 2025-11-15 | Integra LifeSciences Corporation | $14 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2025 | |
| 2025-11-14 | Integra LifeSciences Corporation | $19 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2025 | |
| 2025-11-13 | GENZYME CORPORATION | $3,283 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | DUPIXENT Biological, Immunology | 2025 | |
| 2025-11-12 | GENZYME CORPORATION | $3,283 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | DUPIXENT Biological, Immunology | 2025 | |
| 2025-10-30 | GENZYME CORPORATION | $9,849 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | DUPIXENT Biological, Immunology | 2025 | |
| 2025-10-30 | GENZYME CORPORATION | $5,159 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | DUPIXENT Biological, Immunology | 2025 | |
| 2025-10-30 | GENZYME CORPORATION | $159 | Travel and Lodging | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-10-30 | GENZYME CORPORATION | $120 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-10-16 | Regeneron Healthcare Solutions, Inc. | $34 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-10-15 | Neurent Medical Limited | $1,000 | Consulting Fee | Cash or cash equivalent | NEUROMARK System Device, Electrosurgical, Cutting & Coagulation & Accessories | 2025 | |
| 2025-10-15 | Neurent Medical Limited | $500 | Consulting Fee | Cash or cash equivalent | NEUROMARK System Device, Electrosurgical, Cutting & Coagulation & Accessories | 2025 | |
| 2025-10-12 | Integra LifeSciences Corporation | $102 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2025 | |
| 2025-10-12 | Neurent Medical Limited | $73 | Food and Beverage | Cash or cash equivalent | NEUROMARK System Device, Electrosurgical, Cutting & Coagulation & Accessories | 2025 | |
| 2025-10-12 | Integra LifeSciences Corporation | $38 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2025 | |
| 2025-10-12 | Integra LifeSciences Corporation | $35 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2025 | |
| 2025-10-12 | Neurent Medical Limited | $28 | Food and Beverage | Cash or cash equivalent | NEUROMARK System Device, Electrosurgical, Cutting & Coagulation & Accessories | 2025 | |
| 2025-10-11 | Integra LifeSciences Corporation | $38 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2025 | |
| 2025-10-10 | GlaxoSmithKline, LLC. | $43 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-10-10 | Integra LifeSciences Corporation | $34 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2025 | |
| 2025-10-10 | Regeneron Healthcare Solutions, Inc. | $25 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-10-10 | Neurent Medical Limited | $16 | Food and Beverage | Cash or cash equivalent | NEUROMARK System Device, Electrosurgical, Cutting & Coagulation & Accessories | 2025 | |
| 2025-09-23 | Regeneron Healthcare Solutions, Inc. | $25 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-09-03 | GENZYME CORPORATION | $42 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-08-18 | Integra LifeSciences Corporation | $11,812 | Consulting Fee | Cash or cash equivalent | OMNIGRAFT Device, Recon-Skin and Wound | 2025 | |
| 2025-08-15 | Integra LifeSciences Corporation | $169 | Food and Beverage | In-kind items and services | Integra Device, Precision Tools & Instruments | 2025 | |
| 2025-08-14 | Regeneron Healthcare Solutions, Inc. | $5 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-08-13 | Integra LifeSciences Corporation | $146 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2025 | |
| 2025-08-13 | Integra LifeSciences Corporation | $21 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2025 | |
| 2025-08-08 | Neurent Medical Limited | $2,812 | Research payment | Cash or cash equivalent | NEUROMARK System Device, Electrosurgical, Cutting & Coagulation & Accessories | Gen 3 Study | 2025 |
| 2025-07-12 | Neurent Medical Limited | $500 | Consulting Fee | Cash or cash equivalent | NEUROMARK System Device, Electrosurgical, Cutting & Coagulation & Accessories | 2025 | |
| 2025-07-12 | Integra LifeSciences Corporation | $137 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2025 | |
| 2025-07-12 | Medtronic, Inc. | $85 | Food and Beverage | In-kind items and services | STRAIGHTSHOT Device, High Speed Surgical Drills and Tools | 2025 | |
| 2025-07-10 | Neurent Medical Limited | $93 | Food and Beverage | Cash or cash equivalent | NEUROMARK System Device, Electrosurgical, Cutting & Coagulation & Accessories | 2025 | |
| 2025-07-10 | Neurent Medical Limited | $11 | Food and Beverage | Cash or cash equivalent | NEUROMARK System Device, Electrosurgical, Cutting & Coagulation & Accessories | 2025 | |
| 2025-06-30 | Integra LifeSciences Corporation | $54 | Travel and Lodging | Cash or cash equivalent | Integra Device, Recon-Skin and Wound | 2025 | |
| 2025-06-24 | GlaxoSmithKline, LLC. | $64 | Education | In-kind items and services | 2025 | ||
| 2025-06-23 | Integra LifeSciences Corporation | $31 | Travel and Lodging | Cash or cash equivalent | Integra Device, Recon-Skin and Wound | 2025 | |
| 2025-06-23 | Integra LifeSciences Corporation | $15 | Travel and Lodging | Cash or cash equivalent | Integra Device, Recon-Skin and Wound | 2025 | |
| 2025-06-23 | Integra LifeSciences Corporation | $12 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2025 | |
| 2025-06-22 | Neurent Medical Limited | $255 | Food and Beverage | Cash or cash equivalent | NEUROMARK System Device, Electrosurgical, Cutting & Coagulation & Accessories | 2025 | |
| 2025-06-22 | Integra LifeSciences Corporation | $15 | Travel and Lodging | Cash or cash equivalent | Integra Device, Recon-Skin and Wound | 2025 | |
| 2025-06-20 | Regeneron Healthcare Solutions, Inc. | $2,345 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-06-20 | Integra LifeSciences Corporation | $406 | Travel and Lodging | Cash or cash equivalent | Integra Device, Recon-Skin and Wound | 2025 | |
| 2025-06-20 | Integra LifeSciences Corporation | $19 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2025 | |
| 2025-06-19 | Integra LifeSciences Corporation | $105 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2025 | |
| 2025-06-19 | Integra LifeSciences Corporation | $45 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2025 | |
| 2025-06-19 | Integra LifeSciences Corporation | $20 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2025 | |
| 2025-06-16 | Neurent Medical Limited | $32 | Food and Beverage | Cash or cash equivalent | NEUROMARK System Device, Electrosurgical, Cutting & Coagulation & Accessories | 2025 | |
| 2025-06-12 | Regeneron Healthcare Solutions, Inc. | $26 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-06-10 | GENZYME CORPORATION | $46 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2025 | |
| 2025-06-05 | Regeneron Healthcare Solutions, Inc. | $5 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-06-04 | GENZYME CORPORATION | $1,728 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-05-17 | Regeneron Healthcare Solutions, Inc. | $40 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-05-16 | Neurent Medical Limited | $99 | Food and Beverage | Cash or cash equivalent | NEUROMARK System Device, Electrosurgical, Cutting & Coagulation & Accessories | 2025 | |
| 2025-05-16 | Neurent Medical Limited | $47 | Food and Beverage | Cash or cash equivalent | NEUROMARK System Device, Electrosurgical, Cutting & Coagulation & Accessories | 2025 | |
| 2025-05-16 | Neurent Medical Limited | $32 | Food and Beverage | Cash or cash equivalent | NEUROMARK System Device, Electrosurgical, Cutting & Coagulation & Accessories | 2025 | |
| 2025-05-16 | Medtronic, Inc. | $14 | Food and Beverage | In-kind items and services | STRAIGHTSHOT Device, High Speed Surgical Drills and Tools | 2025 | |
| 2025-04-22 | Regeneron Healthcare Solutions, Inc. | $703 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-04-22 | Regeneron Healthcare Solutions, Inc. | $31 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-04-15 | Regeneron Healthcare Solutions, Inc. | $500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-04-08 | Optinose US, Inc. | $1,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2025 | |
| 2025-03-07 | Regeneron Healthcare Solutions, Inc. | $92 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-02-27 | Regeneron Healthcare Solutions, Inc. | $30 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-02-20 | ARS Pharmaceuticals Operations, Inc. | $18 | Food and Beverage | In-kind items and services | NEFFY Drug, ALLERGY | 2025 | |
| 2025-02-13 | Regeneron Healthcare Solutions, Inc. | $37 | Food and Beverage | In-kind items and services | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-02-06 | Optinose US, Inc. | $24 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2025 | |
| 2025-01-10 | Neurent Medical Limited | $23,825 | Research payment | Cash or cash equivalent | NEUROMARK System Device, Electrosurgical, Cutting & Coagulation & Accessories | Gen 3 Study | 2025 |
| 2024-12-20 | Integra LifeSciences Corporation | $18 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2024 | |
| 2024-12-13 | Neurent Medical Limited | $750 | Consulting Fee | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2024 | |
| 2024-12-12 | Neurent Medical Limited | $1,875 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | Gen 3 Study | 2024 |
| 2024-12-11 | Neurent Medical Limited | $57 | Consulting Fee | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2024 | |
| 2024-12-10 | Medtronic, Inc. | $59 | Food and Beverage | In-kind items and services | Sinuva Drug, Otolaryngology (Ear, Nose, Throat) | 2024 | |
| 2024-11-20 | Regeneron Healthcare Solutions, Inc. | $28 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2024 | |
| 2024-11-19 | Neurent Medical Limited | $19 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2024 | |
| 2024-11-12 | Integra LifeSciences Corporation | $166 | Food and Beverage | In-kind items and services | Integra Device, Precision Tools & Instruments | 2024 | |
| 2024-11-12 | Integra LifeSciences Corporation | $110 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2024 | |
| 2024-11-04 | Optinose US, Inc. | $9 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2024 | |
| 2024-10-31 | Regeneron Healthcare Solutions, Inc. | $26 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2024 | |
| 2024-10-30 | Neurent Medical Limited | $7,000 | Consulting Fee | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2024 | |
| 2024-10-30 | Neurent Medical Limited | $4,202 | Travel and Lodging | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2024 | |
| 2024-10-27 | Neurent Medical Limited | $34 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2024 | |
| 2024-10-27 | Neurent Medical Limited | $20 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2024 | |
| 2024-10-26 | Neurent Medical Limited | $160 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2024 | |
| 2024-10-24 | Neurent Medical Limited | $110 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2024 | |
| 2024-10-24 | Neurent Medical Limited | $16 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2024 | |
| 2024-10-24 | Neurent Medical Limited | $15 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2024 | |
| 2024-10-24 | Neurent Medical Limited | $14 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2024 | |
| 2024-10-23 | Neurent Medical Limited | $4 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2024 | |
| 2024-10-15 | Neurent Medical Limited | $9,835 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | NEUROMARK Randomized Controlled Trial | 2024 |
| 2024-10-15 | Neurent Medical Limited | $5,507 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | Clinical Evaluation of Safety and Efficacy for the NEUROMARK System in Subjects With Chronic Rhinitis (PARAGON) | 2024 |
| 2024-10-15 | Neurent Medical Limited | $907 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | Nexus Study - Clinical Exploration of NEUROMARK System in Subjects With Chronic Rhinosinusitis (CRS) | 2024 |
| 2024-10-09 | Neurent Medical Limited | $39 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2024 | |
| 2024-10-03 | Optinose US, Inc. | $7 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2024 | |
| 2024-09-30 | Integra LifeSciences Corporation | $41 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2024 | |
| 2024-09-29 | Integra LifeSciences Corporation | $48 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2024 | |
| 2024-09-27 | Neurent Medical Limited | $168 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2024 | |
| 2024-09-27 | Neurent Medical Limited | $83 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2024 | |
| 2024-09-27 | Regeneron Healthcare Solutions, Inc. | $54 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2024 | |
| 2024-09-26 | Integra LifeSciences Corporation | $172 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2024 | |
| 2024-09-26 | Medtronic, Inc. | $65 | Food and Beverage | In-kind items and services | PROPEL Device, Otolaryngology (Ear, Nose, Throat) | 2024 | |
| 2024-09-16 | Neurent Medical Limited | $98 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2024 | |
| 2024-09-13 | Integra LifeSciences Corporation | $20 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2024 | |
| 2024-09-09 | Regeneron Healthcare Solutions, Inc. | $31 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2024 | |
| 2024-08-16 | Integra LifeSciences Corporation | $136 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2024 | |
| 2024-08-16 | Integra LifeSciences Corporation | $30 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2024 | |
| 2024-08-15 | Integra LifeSciences Corporation | $175 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2024 | |
| 2024-08-15 | Integra LifeSciences Corporation | $31 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2024 | |
| 2024-08-15 | Integra LifeSciences Corporation | $26 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2024 | |
| 2024-08-01 | Optinose US, Inc. | $1,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2024 | |
| 2024-07-25 | Optinose US, Inc. | $1,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2024 | |
| 2024-07-19 | Regeneron Healthcare Solutions, Inc. | $57 | Education | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2024 | |
| 2024-07-18 | Integra LifeSciences Corporation | $23 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2024 | |
| 2024-07-16 | Integra LifeSciences Corporation | $5,000 | Consulting Fee | Cash or cash equivalent | ACCLARENT AERA Device, ENT | 2024 | |
| 2024-07-16 | Integra LifeSciences Corporation | $2,500 | Consulting Fee | Cash or cash equivalent | ACCLARENT AERA Device, ENT | 2024 | |
| 2024-07-16 | Integra LifeSciences Corporation | $191 | Travel and Lodging | Cash or cash equivalent | ACCLARENT AERA Device, ENT | 2024 | |
| 2024-07-16 | Integra LifeSciences Corporation | $22 | Travel and Lodging | Cash or cash equivalent | ACCLARENT AERA Device, ENT | 2024 | |
| 2024-07-16 | Integra LifeSciences Corporation | $16 | Food and Beverage | Cash or cash equivalent | ACCLARENT AERA Device, ENT | 2024 | |
| 2024-06-28 | Neurent Medical Limited | $2,750 | Consulting Fee | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2024 | |
| 2024-06-13 | Integra LifeSciences Corporation | $28 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2024 | |
| 2024-06-11 | Integra LifeSciences Corporation | $136 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2024 | |
| 2024-05-24 | Integra LifeSciences Corporation | $472 | Travel and Lodging | In-kind items and services | ACCLARENT AERA Device, ENT | 2024 | |
| 2024-05-24 | Integra LifeSciences Corporation | $221 | Travel and Lodging | Cash or cash equivalent | ACCLARENT AERA Device, ENT | 2024 | |
| 2024-05-16 | Integra LifeSciences Corporation | $3,500 | Consulting Fee | Cash or cash equivalent | ACCLARENT AERA Device, ENT | 2024 | |
| 2024-05-10 | Stryker Corporation | $18 | Food and Beverage | In-kind items and services | SCOPIS ENT Device, INSTRUMENTS | 2024 | |
| 2024-05-07 | Regeneron Healthcare Solutions, Inc. | $33 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2024 | |
| 2024-04-22 | Integra LifeSciences Corporation | $32 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2024 | |
| 2024-04-18 | Integra LifeSciences Corporation | $161 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2024 | |
| 2024-04-18 | Integra LifeSciences Corporation | $17 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2024 | |
| 2024-04-11 | Neurent Medical Limited | $3,800 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (CLARITY) | 2024 |
| 2024-04-04 | Integra LifeSciences Corporation | $130 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2024 | |
| 2024-04-04 | Integra LifeSciences Corporation | $44 | Food and Beverage | In-kind items and services | ACCLARENT AERA Device, ENT | 2024 | |
| 2024-04-02 | Neurent Medical Limited | $2,000 | Consulting Fee | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2024 | |
| 2024-03-26 | Acclarent, Inc | $3,000 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-03-26 | Acclarent, Inc | $500 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-03-26 | Acclarent, Inc | $34 | Food and Beverage | In-kind items and services | RELIEVA SPINPLUS Device, Rhinology | 2024 | |
| 2024-03-08 | Acclarent, Inc | $27 | Food and Beverage | In-kind items and services | Acclarent Navwire Device, Rhinology Otology Laryngology Neurosurgery | 2024 | |
| 2024-01-31 | Neurent Medical Limited | $2,662 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | Nexus Study - Clinical Exploration of NEUROMARK System in Subjects With Chronic Rhinosinusitis (CRS) | 2024 |
| 2024-01-31 | Neurent Medical Limited | $2,638 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | NEUROMARK Randomized Controlled Trial | 2024 |
| 2024-01-31 | Neurent Medical Limited | $2,002 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | Clinical Evaluation of Safety and Efficacy for the NEUROMARK System in Subjects With Chronic Rhinitis (PARAGON) | 2024 |
| 2024-01-11 | Regeneron Healthcare Solutions, Inc. | $23 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2024 | |
| 2024-01-04 | Neurent Medical Limited | $97 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2024 | |
| 2023-12-15 | Neurent Medical Limited | $13 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2023 | |
| 2023-12-13 | Acclarent, Inc | $1,000 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-12-08 | Acclarent, Inc | $14 | Food and Beverage | In-kind items and services | TruDi NAV Cable Device, Rhinology Otology Laryngology Neurosurgery | 2023 | |
| 2023-12-06 | Optinose US, Inc. | $1,100 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2023 | |
| 2023-11-27 | Acclarent, Inc | $10 | Food and Beverage | In-kind items and services | TruDi NAV Cable Device, Rhinology Otology Laryngology Neurosurgery | 2023 | |
| 2023-11-07 | Optinose US, Inc. | $15 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2023 | |
| 2023-10-30 | Acclarent, Inc | $8 | Food and Beverage | In-kind items and services | TruDi NAV Cable Device, Rhinology Otology Laryngology Neurosurgery | 2023 | |
| 2023-10-27 | Acclarent, Inc | $4 | Food and Beverage | In-kind items and services | TruDi NAV Cable Device, Rhinology Otology Laryngology Neurosurgery | 2023 | |
| 2023-10-25 | Optinose US, Inc. | $8 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2023 | |
| 2023-10-20 | Neurent Medical Limited | $3,438 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | Clinical Evaluation of Safety and Efficacy for the NEUROMARK System in Subjects With Chronic Rhinitis (PARAGON) | 2023 |
| 2023-10-20 | Neurent Medical Limited | $500 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (CLARITY) | 2023 |
| 2023-10-20 | Regeneron Healthcare Solutions, Inc. | $24 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2023 | |
| 2023-10-13 | Optinose US, Inc. | $825 | Consulting Fee | Cash or cash equivalent | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2023 | |
| 2023-10-12 | Acclarent, Inc | $22 | Food and Beverage | In-kind items and services | Acclarent Navwire Device, Rhinology Otology Laryngology Neurosurgery | 2023 | |
| 2023-10-03 | Acclarent, Inc | $139 | Food and Beverage | In-kind items and services | Acclarent Navwire Device, Rhinology Otology Laryngology Neurosurgery | 2023 | |
| 2023-10-01 | Neurent Medical Limited | $144 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2023 | |
| 2023-10-01 | Acclarent, Inc | $120 | Food and Beverage | In-kind items and services | ACCLARENT Balloon Inflation Device Device, Rhinology Laryngology | 2023 | |
| 2023-10-01 | Medtronic, Inc. | $56 | Food and Beverage | In-kind items and services | STRAIGHTSHOT Device, High Speed Surgical Drills and Tools | 2023 | |
| 2023-10-01 | Acclarent, Inc | $56 | Food and Beverage | In-kind items and services | Acclarent Navwire Device, Rhinology Otology Laryngology Neurosurgery | 2023 | |
| 2023-10-01 | Neurent Medical Limited | $43 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2023 | |
| 2023-10-01 | Medtronic, Inc. | $29 | Food and Beverage | In-kind items and services | PROPEL Device, Otolaryngology (Ear, Nose, Throat) | 2023 | |
| 2023-10-01 | Neurent Medical Limited | $23 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2023 | |
| 2023-10-01 | Neurent Medical Limited | $19 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2023 | |
| 2023-09-30 | GlaxoSmithKline, LLC. | $58 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-09-30 | SANOFI-AVENTIS U.S. LLC | $33 | Food and Beverage | In-kind items and services | DUPIXENT Biological, Immunology | 2023 | |
| 2023-09-29 | AstraZeneca Pharmaceuticals LP | $79 | Food and Beverage | In-kind items and services | AIRSUPRA Drug, Respiratory | 2023 | |
| 2023-09-26 | Optinose US, Inc. | $21 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2023 | |
| 2023-09-25 | Acclarent, Inc | $18 | Food and Beverage | In-kind items and services | Acclarent Navwire Device, Rhinology Otology Laryngology Neurosurgery | 2023 | |
| 2023-09-16 | Acclarent, Inc | $19 | Food and Beverage | In-kind items and services | Relieva Tract Device | 2023 | |
| 2023-09-10 | Acclarent, Inc | $39 | Food and Beverage | In-kind items and services | Acclarent Aera Device, Rhinology Otology | 2023 | |
| 2023-08-24 | Regeneron Healthcare Solutions, Inc. | $24 | Food and Beverage | In-kind items and services | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | 2023 | |
| 2023-08-18 | Acclarent, Inc | $18 | Food and Beverage | In-kind items and services | Acclarent Aera Device, Rhinology Otology | 2023 | |
| 2023-08-04 | Neurent Medical Limited | $2,430 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | Nexus Study - Clinical Exploration of NEUROMARK System in Subjects With Chronic Rhinosinusitis (CRS) | 2023 |
| 2023-07-16 | AERIN MEDICAL INC. | $69 | Food and Beverage | In-kind items and services | VIVAER STYLUS Device, EAR NOSE & THROAT | 2023 | |
| 2023-07-15 | Acclarent, Inc | $98 | Food and Beverage | In-kind items and services | TruDi NAV Cable Device, Rhinology Otology Laryngology Neurosurgery | 2023 | |
| 2023-07-14 | Neurent Medical Limited | $7,500 | Consulting Fee | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2023 | |
| 2023-07-14 | Neurent Medical Limited | $5,738 | Travel and Lodging | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2023 | |
| 2023-07-14 | Neurent Medical Limited | $166 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2023 | |
| 2023-07-13 | Neurent Medical Limited | $98 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2023 | |
| 2023-07-13 | Acclarent, Inc | $86 | Food and Beverage | In-kind items and services | TruDi NAV Cable Device, Rhinology Otology Laryngology Neurosurgery | 2023 | |
| 2023-07-13 | Neurent Medical Limited | $71 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2023 | |
| 2023-06-30 | Neurent Medical Limited | $2,425 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (MERIDIEN) | 2023 |
| 2023-06-30 | Acclarent, Inc | $37 | Food and Beverage | In-kind items and services | Acclarent Navwire Device, Rhinology Otology Laryngology Neurosurgery | 2023 | |
| 2023-06-25 | Neurent Medical Limited | $164 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2023 | |
| 2023-06-25 | Neurent Medical Limited | $26 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2023 | |
| 2023-06-24 | Neurent Medical Limited | $112 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2023 | |
| 2023-06-23 | Neurent Medical Limited | $93 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2023 | |
| 2023-06-16 | AERIN MEDICAL INC. | $25 | Food and Beverage | In-kind items and services | VIVAER STYLUS Device, EAR NOSE & THROAT | 2023 | |
| 2023-06-08 | Optinose US, Inc. | $21 | Food and Beverage | In-kind items and services | Xhance Drug, Otolaryngology (Ear, Nose, Throat) | 2023 | |
| 2023-05-30 | Neurent Medical Limited | $12,062 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | Clinical Evaluation of Safety and Efficacy for the NEUROMARK System in Subjects With Chronic Rhinitis (PARAGON) | 2023 |
| 2023-05-30 | Neurent Medical Limited | $4,250 | Research payment | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (CLARITY) | 2023 |
| 2023-05-20 | Acclarent, Inc | $30 | Food and Beverage | In-kind items and services | Acclarent Aera Device, Rhinology Otology | 2023 | |
| 2023-05-11 | Medical Device Business Services, Inc. | $2,500 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-05-06 | Neurent Medical Limited | $30 | Food and Beverage | Cash or cash equivalent | NEUROMARK Device Device, Electrosurgical, Cutting & Coagulation & Accessories | 2023 | |
| 2023-03-29 | Acclarent, Inc | $97 | Food and Beverage | In-kind items and services | Acclarent Navwire Device, Rhinology Otology Laryngology Neurosurgery | 2023 | |
| 2023-03-29 | Acclarent, Inc | $28 | Food and Beverage | In-kind items and services | Acclarent Aera Device, Rhinology Otology | 2023 | |
| 2023-03-28 | Acclarent, Inc | $126 | Food and Beverage | In-kind items and services | Acclarent Navwire Device, Rhinology Otology Laryngology Neurosurgery | 2023 |
The latest 200 records of 432.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2025-11-14 | Paratek Pharmaceuticals, Inc. | CENTERS FOR ADVANCED ENT CARE - GBMC | $1,764 | A 12-Week Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Intranas | 2025 |
| 2025-11-12 | Paratek Pharmaceuticals, Inc. | CENTERS FOR ADVANCED ENT CARE - GBMC | $262 | A 12-Week Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Intranas | 2025 |
| 2025-09-05 | Optinose US, Inc. | Centers for Advanced ENT Care, LLC | $4,000 | A 12-Week Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Intranas | 2025 |
| 2025-07-25 | GlaxoSmithKline, LLC. | EAR NOSE AND THROAT ASSOCIATES | $900 | REALITI-N: A MULTINATIONAL, OBSERVATIONAL STUDY TO EVALUATE THE REAL-W | 2025 |
| 2024-07-24 | GlaxoSmithKline, LLC. | EAR NOSE AND THROAT ASSOCIATES | $3,000 | REALITI-N: A MULTINATIONAL, OBSERVATIONAL STUDY TO EVALUATE THE REAL-W | 2024 |
| 2023-11-30 | Neurent Medical Limited | GREG E DAVIS | $2,425 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (CLARITY) | 2023 |
| 2023-11-02 | Neurent Medical Limited | JEFFERY S ROSENBLOOM | $2,425 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (MERIDIEN) | 2023 |
| 2023-10-20 | Neurent Medical Limited | MICHAEL JAY SILLERS | $5,094 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (CLARITY) | 2023 |
| 2023-08-31 | Neurent Medical Limited | GREG E DAVIS | $1,000 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (CLARITY) | 2023 |
| 2023-08-04 | Neurent Medical Limited | GREG E DAVIS | $500 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (CLARITY) | 2023 |
| 2023-08-04 | Neurent Medical Limited | DAVID MELICIO YEN | $42,949 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (MERIDIEN) | 2023 |
| 2023-06-30 | Neurent Medical Limited | MICHAEL JAY SILLERS | $13,703 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (CLARITY) | 2023 |
| 2023-05-26 | Neurent Medical Limited | GREG E DAVIS | $750 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (CLARITY) | 2023 |
| 2023-04-28 | Neurent Medical Limited | GREG E DAVIS | $2,375 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (CLARITY) | 2023 |
| 2023-03-31 | Neurent Medical Limited | JEFFERY S ROSENBLOOM | $5,781 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (MERIDIEN) | 2023 |
| 2023-03-10 | Neurent Medical Limited | GREG E DAVIS | $1,125 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (CLARITY) | 2023 |
| 2023-03-03 | Neurent Medical Limited | BRYAN M DAVIS | $2,425 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (MERIDIEN) | 2023 |
| 2023-02-28 | Neurent Medical Limited | GREG E DAVIS | $2,425 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (MERIDIEN) | 2023 |
| 2023-02-17 | Neurent Medical Limited | MICHAEL JAY SILLERS | $16,730 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (CLARITY) | 2023 |
| 2023-02-16 | Neurent Medical Limited | BRYAN M DAVIS | $43,088 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (MERIDIEN) | 2023 |
| 2023-02-15 | Neurent Medical Limited | RANDALL OW | $7,124 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (MERIDIEN) | 2023 |
| 2023-02-13 | Neurent Medical Limited | GREG E DAVIS | $1,500 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (CLARITY) | 2023 |
| 2023-02-13 | Neurent Medical Limited | GREG E DAVIS | $2,126 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (MERIDIEN) | 2023 |
| 2022-12-28 | Neurent Medical Limited | GREG E DAVIS | $1,063 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (MERIDIEN) | 2022 |
| 2022-12-28 | Neurent Medical Limited | GREG E DAVIS | $500 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (CLARITY) | 2022 |
| 2022-12-05 | Neurent Medical Limited | MARC G DUBIN | $10,968 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (MERIDIEN) | 2022 |
| 2022-12-05 | Neurent Medical Limited | MARC G DUBIN | $8,187 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (CLARITY) | 2022 |
| 2022-11-30 | Neurent Medical Limited | GREG E DAVIS | $1,063 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (MERIDIEN) | 2022 |
| 2022-11-30 | Neurent Medical Limited | ADIL FATAKIA | $1,397 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (MERIDIEN) | 2022 |
| 2022-11-30 | Neurent Medical Limited | GREG E DAVIS | $1,250 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (CLARITY) | 2022 |
| 2022-11-01 | Neurent Medical Limited | MICHAEL JAY SILLERS | $35,365 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (CLARITY) | 2022 |
| 2022-10-31 | Neurent Medical Limited | RANDALL OW | $13,748 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (MERIDIEN) | 2022 |
| 2022-10-31 | Neurent Medical Limited | GREG E DAVIS | $1,250 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (CLARITY) | 2022 |
| 2022-09-30 | Neurent Medical Limited | JEFFERY S ROSENBLOOM | $2,313 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (MERIDIEN) | 2022 |
| 2022-09-30 | Neurent Medical Limited | GREG E DAVIS | $1,000 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (CLARITY) | 2022 |
| 2022-09-30 | Neurent Medical Limited | GREG E DAVIS | $2,126 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (MERIDIEN) | 2022 |
| 2022-09-30 | Neurent Medical Limited | MICHAEL JAY SILLERS | $3,908 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (MERIDIEN) | 2022 |
| 2022-09-23 | Neurent Medical Limited | BRYAN M DAVIS | $49,553 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (MERIDIEN) | 2022 |
| 2022-09-09 | Neurent Medical Limited | ADIL FATAKIA | $2,956 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (MERIDIEN) | 2022 |
| 2022-09-09 | Neurent Medical Limited | MICHAEL JAY SILLERS | $4,208 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (MERIDIEN) | 2022 |
| 2022-08-26 | Neurent Medical Limited | GREG E DAVIS | $2,126 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (MERIDIEN) | 2022 |
| 2022-08-26 | Neurent Medical Limited | GREG E DAVIS | $8,964 | Safety and Efficacy Study of the Neurent Medical NEUROMARK System in Subjects With Chronic Rhinitis (CLARITY) | 2022 |
| 2021-10-13 | Optinose US, Inc. | Centers for Advanced ENT Care, LLC | $2,870 | A 24-Week Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating the Efficacy and Sa | 2021 |
| 2021-06-15 | AERIN MEDICAL INC. | CENTERS FOR ADVANCED ENT CARE | $3,102 | CTP 1006 - VATRAC | 2021 |
| 2021-02-01 | AERIN MEDICAL INC. | CENTERS FOR ADVANCED ENT CARE | $2,000 | CTP 1006 - VATRAC | 2021 |
| 2021-01-12 | Optinose US, Inc. | Centers for Advanced ENT Care, LLC | $2,243 | A 24-Week Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating the Efficacy and Sa | 2021 |
| 2020-10-14 | Optinose US, Inc. | Centers for Advanced ENT Care, LLC | $5,092 | A 24-Week Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating the Efficacy and Sa | 2020 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Baltimore, MD, county Baltimore city, MD, state Maryland; placed by its city name.
| Measure | Place (city or town) Baltimore, MD | County Baltimore city, MD | State Maryland |
|---|---|---|---|
| Population B01003 | 573,243 | 573,243 | 6,206,011 |
| Population, 2020 census P1 | 585,708 | 585,708 | 6,177,224 |
| Median age B01002 | 36.2 | 36.2 | 39.4 |
| Under 18 B01001 | 20.9% | 20.9% | 22.2% |
| 65 and over B01001 | 15.3% | 15.3% | 16.7% |
| Households B11001 | 255,668 | 255,668 | 2,362,928 |
| Foreign born B05002 | 9.3% | 9.3% | 16.6% |
| Median household income B19013 | $62,177 | $62,177 | $103,678 |
| Median family income B19113 | $76,243 | $76,243 | $127,817 |
| Per capita income B19301 | $40,604 | $40,604 | $52,979 |
| Poverty rate B17001 | 19.7% | 19.7% | 9.4% |
| Unemployment rate B23025 | 6.5% | 6.5% | 4.9% |
| Civilian labor force B23025 | 294,134 | 294,134 | 3,313,651 |
| Mean commute (minutes) B08013 | 29.1 | 29.1 | 31.1 |
| Bachelor's degree or higher B15003 | 36.1% | 36.1% | 43.4% |
| Housing units B25001 | 295,032 | 295,032 | 2,560,784 |
| Owner-occupied B25003 | 47.5% | 47.5% | 67.6% |
| Renters B25003 | 52.5% | 52.5% | 32.4% |
| Median home value B25077 | $229,600 | $229,600 | $419,900 |
| Median gross rent B25064 | $1,331 | $1,331 | $1,705 |
| White, not Hispanic B03002 | 26.0% | 26.0% | 46.6% |
| Black B03002 | 58.5% | 58.5% | 28.9% |
| Hispanic or Latino B03002 | 8.2% | 8.2% | 12.5% |
| Asian B03002 | 2.6% | 2.6% | 6.5% |
| American Indian and Alaska Native B03002 | 0.2% | 0.2% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Baltimore, MD.
Comments